This content is protected against AI scraping.
Cannabis consumers are officially giving federal weed reform a collective side-eye. Back in April, the administration fast-tracked a move that bumped medical marijuana down to Schedule 3, and right now, a DEA judge is holding hearings to decide if the rest of the cannabis market should follow suit. But according to a new poll by NuggMD, a slim majority of consumers (52.5%) are aggressively pessimistic, betting that full rescheduling won’t actually cross the finish line by the end of the year.
Honestly, the skepticism makes sense given how heavily gatekept the process has been—the DEA literally banned the public from livestreaming the hearings, and pro-reform advocates were barred from participating. Still, there’s a weirdly positive plot twist: early testimony has actually been surprisingly favorable, putting government evidence on the record that cannabis has legitimate medical value and is safer than alcohol. The hearings are set to wrap up by July 15, but with the timeline entirely up to DEA bureaucrats, consumers are bracing themselves for a classic government slow-roll.
This is a summary.
Please read the original article: Most Marijuana Consumers Don’t Believe Trump Administration Will Complete Rescheduling This Year, Poll Shows
Original article written by Tom Angell. Published on July 8, 2026 by Marijuana Moment.
